Archives

D-Wave Quantum Inc. announced on July 27, 2026, that AT&T has signed an agreement to expand its deployment of D-Wave's quantum computing technology across network operations and emerging security applications. The partnership will integrate D-Wave's annealing quantum systems into AT&T's agentic AI solutions, which have already generated measurable operational improvements, while AT&T evaluates D-Wave's forthcoming gate-model systems for quantum security and communications use cases.

• July 27, 2026 07:30 AM PDT
• Manish Choudhary

HBT Financial, Inc., a Bloomington, Illinois-based financial institution, announced on July 27, 2026 that its Board of Directors has increased the quarterly cash dividend by $0.02 per share to $0.25 per share, representing a 9 percent increase from the prior dividend level. The announcement accompanied the company's disclosure of financial results for the second quarter and first half of 2026, signaling confidence in operational performance and shareholder returns during a dynamic banking environment.

• July 27, 2026 07:30 AM PDT
• Vinay Lochav

MapLight Therapeutics, Inc. announced on July 27, 2026, the topline results from the ZEPHYR Phase 2 trial evaluating ML-007C-MA in inpatient adult participants with schizophrenia experiencing acute exacerbation of psychosis. The company disclosed the results through a conference call and accompanying presentation on the same date. This disclosure marks a significant development in the company's clinical pipeline for a psychiatric indication requiring hospitalization.

• July 27, 2026 07:29 AM PDT
• Aakashdeep

Neumora Therapeutics, Inc. (NASDAQ: NMRA) announced favorable pre-clinical toxicology results from NMRA-215, its investigational therapeutic candidate, according to a disclosure filed on July 27, 2026. The announcement signals progress in the company's development pipeline and comes as the biopharmaceutical firm advances its clinical-stage programs. The results may be relevant to investors tracking the company's pipeline advancement and regulatory pathway decisions.

• July 27, 2026 07:29 AM PDT
• Shwetambri Chauhan

Ponce Financial Group, Inc., the parent company of Ponce Bank, disclosed its financial results for the second quarter ended June 30, 2026, on July 27, 2026. The announcement included a press release outlining operational and financial performance metrics alongside a formal investor presentation. The disclosure signals the company's continued engagement with capital markets and provides shareholders with updated performance data at the midway point of the fiscal year.

• July 27, 2026 07:29 AM PDT
• Anjali Anand

Boost Run Inc. (NASDAQ: BRUN) announced on July 27, 2026, that it delivered a notice of redemption for all outstanding warrants on July 21, 2026, with a redemption deadline set for August 20, 2026. The company has already received $58.8 million in gross cash proceeds from warrant exercises as of July 24, 2026, representing approximately 45% of total public warrants exercised. If remaining warrant holders exercise their rights before the redemption date, the company projects total proceeds could reach $131.9 million.

• July 27, 2026 07:29 AM PDT
• Anjali Anand

Precision BioSciences, Inc. announced significant changes to its executive leadership team effective August 1, 2026. Alex Kelly, who has served as Chief Financial Officer since May 2021, was promoted to Chief Operating Officer with an increased annual base salary of $510,000. Naresh Tanna, who previously held the position of Vice President of Investor Relations and Chief of Staff, was appointed as the new Chief Financial Officer with a base salary of $400,000. The reorganization also includes the promotion of Mei Burris to principal accounting officer and Chief Accounting Officer.

• July 27, 2026 07:29 AM PDT
• Vinay Lochav

Strive, Inc. announced on July 27, 2026, that it has acquired 79 bitcoin during the week of July 20–24, 2026, at an average price of approximately $65,723 per bitcoin inclusive of fees and expenses. The purchase brings the company's total bitcoin holdings to 20,000 BTC, reflecting continued execution of its digital asset treasury strategy. The disclosure also includes updated positions across cash, preferred stock holdings, and share capitalization metrics as of July 24, 2026.

• July 27, 2026 07:29 AM PDT
• Aakashdeep

Strategy Inc (NASDAQ: MSTR) disclosed on July 27, 2026, that it sold 5.4 million shares of Class A common stock generating $544.5 million in net proceeds during the week of July 20-26, 2026. The company simultaneously repurchased 288,930 shares of Variable Rate Series A Perpetual Stretch Preferred Stock for $25.0 million, signaling active capital management across multiple security classes. Strategy also reported maintaining substantial capacity under its at-the-market offering program and disclosed updated bitcoin holdings of 843,775 BTC valued at $63.69 billion in aggregate.

• July 27, 2026 07:29 AM PDT
• Anjali Anand

Kyverna Therapeutics, Inc. has entered into a new Clinical and Commercial Supply Agreement with ElevateBio Basecamp, Inc. effective July 23, 2026, replacing a prior development and manufacturing services arrangement. The agreement establishes a structured framework for the production and supply of mivocabtagene autoleucel (miv-cel), the company's lead product candidate, with an initial five-year term and automatic renewal provisions. The arrangement includes minimum purchase commitments and pricing adjustments tied to inflation metrics, positioning the company for scaled manufacturing as it advances miv-cel toward potential regulatory approval.

• July 27, 2026 07:28 AM PDT
• Anjali Anand